JP2014507414A5 - - Google Patents

Download PDF

Info

Publication number
JP2014507414A5
JP2014507414A5 JP2013549769A JP2013549769A JP2014507414A5 JP 2014507414 A5 JP2014507414 A5 JP 2014507414A5 JP 2013549769 A JP2013549769 A JP 2013549769A JP 2013549769 A JP2013549769 A JP 2013549769A JP 2014507414 A5 JP2014507414 A5 JP 2014507414A5
Authority
JP
Japan
Prior art keywords
thiobutoxy
thiophen
benzo
under reduced
carbon atoms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2013549769A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014507414A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2012/050297 external-priority patent/WO2012098033A1/en
Publication of JP2014507414A publication Critical patent/JP2014507414A/ja
Publication of JP2014507414A5 publication Critical patent/JP2014507414A5/ja
Pending legal-status Critical Current

Links

JP2013549769A 2011-01-19 2012-01-10 代謝疾患及び炎症疾患の治療に有用なアゼチジン誘導体 Pending JP2014507414A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161434077P 2011-01-19 2011-01-19
US61/434,077 2011-01-19
PCT/EP2012/050297 WO2012098033A1 (en) 2011-01-19 2012-01-10 Azetidine derivatives useful for the treatment of metabolic and inflammatory diseases

Publications (2)

Publication Number Publication Date
JP2014507414A JP2014507414A (ja) 2014-03-27
JP2014507414A5 true JP2014507414A5 (enExample) 2015-03-12

Family

ID=45507689

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013549769A Pending JP2014507414A (ja) 2011-01-19 2012-01-10 代謝疾患及び炎症疾患の治療に有用なアゼチジン誘導体

Country Status (18)

Country Link
US (2) US8759334B2 (enExample)
EP (1) EP2665704A1 (enExample)
JP (1) JP2014507414A (enExample)
KR (1) KR20140040104A (enExample)
CN (1) CN103328442A (enExample)
AR (1) AR084857A1 (enExample)
AU (1) AU2012208693B2 (enExample)
BR (1) BR112013018286A2 (enExample)
CA (1) CA2824460A1 (enExample)
CO (1) CO6741223A2 (enExample)
GB (1) GB2489382A (enExample)
MX (1) MX2013008257A (enExample)
PH (1) PH12013501437A1 (enExample)
RU (1) RU2013138372A (enExample)
SG (1) SG191291A1 (enExample)
TW (1) TW201245144A (enExample)
WO (1) WO2012098033A1 (enExample)
ZA (1) ZA201304822B (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2824460A1 (en) * 2011-01-19 2012-07-26 Galapagos Nv Azetidine derivatives useful for the treatment of metabolic and inflammatory diseases
KR102259934B1 (ko) 2013-11-27 2021-06-03 에픽스 테라퓨틱스 염증 질환의 치료에 사용되기 위한 화합물, 의약 조성물 및 방법
US9839644B2 (en) 2014-09-09 2017-12-12 ARKAY Therapeutics, LLC Formulations and methods for treatment of metabolic syndrome
KR101656662B1 (ko) * 2014-11-18 2016-09-12 한국생명공학연구원 2-옥소-1,2,3,4-테트라하이드로피리미딘-5-카르복사미드 유도체를 유효성분으로 함유하는 대사성 질환 예방 또는 치료용 약학적 조성물
JP6871856B2 (ja) * 2015-07-07 2021-05-19 日本たばこ産業株式会社 7H−ピロロ[2,3−d]ピリミジン誘導体の製造方法及びその中間体
MX2019007542A (es) 2016-12-21 2019-11-18 Japan Tobacco Inc Proceso para la preparación de derivados de 7h-pirrolo [2, 3-d] pirimidina y sus intermedios sintéticos.
UA126458C2 (uk) 2018-02-13 2022-10-05 Гіліад Сайєнсіз, Інк. Інгібітори pd-1/pd-l1
US10899735B2 (en) 2018-04-19 2021-01-26 Gilead Sciences, Inc. PD-1/PD-L1 inhibitors
CN108863980A (zh) * 2018-07-05 2018-11-23 浙江工业大学 一种合成1-(5-苯并噻唑基)乙酮的方法
EP3820572B1 (en) 2018-07-13 2023-08-16 Gilead Sciences, Inc. Pd-1/pd-l1 inhibitors
AU2019366355B2 (en) 2018-10-24 2022-10-13 Gilead Sciences, Inc. PD-1/PD-L1 inhibitors
CN110684000B (zh) * 2019-10-18 2021-08-31 上海皓元医药股份有限公司 苯并呋喃衍生物的制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5927869A (ja) 1982-08-06 1984-02-14 Sagami Chem Res Center 4−オキソ−4,5,6,7−テトラヒドロインド−ルの製造方法
SG155896A1 (en) * 2004-09-22 2009-10-29 Arena Pharm Inc Gpr43 and modulators thereof for the treatment of metabolic-related disorders
EP1888618A4 (en) * 2005-05-23 2009-07-15 Neuren Pharmaceuticals Ltd Analogs of glycyl-prolyl-glutamate
US20070202515A1 (en) * 2005-10-12 2007-08-30 Pathologica, Llc. Promac signature application
US8252521B2 (en) * 2005-11-04 2012-08-28 Eisai R&D Management Co., Ltd. Method of screening substance useful in treating disease with the use of GPR40 and phospholipase
PE20070978A1 (es) * 2006-02-14 2007-11-15 Novartis Ag COMPUESTOS HETEROCICLICOS COMO INHIBIDORES DE FOSFATIDILINOSITOL 3-QUINASAS (PI3Ks)
WO2008135525A2 (en) * 2007-05-02 2008-11-13 Boehringer Ingelheim International Gmbh Substituted azetidines, manufacturing and use thereof as medicaments
CA2713184A1 (en) 2008-02-21 2009-08-27 Actelion Pharmaceuticals Ltd 2-aza-bicyclo[2.2.1]heptane derivatives
JP2010051307A (ja) * 2008-07-28 2010-03-11 Eisai R & D Management Co Ltd Th17細胞およびTreg細胞の分化誘導を調節する物質のスクリーニング方法
CA2824460A1 (en) * 2011-01-19 2012-07-26 Galapagos Nv Azetidine derivatives useful for the treatment of metabolic and inflammatory diseases

Similar Documents

Publication Publication Date Title
JP2014507414A5 (enExample)
KR101934096B1 (ko) 이델라리십의 제조방법
TWI513691B (zh) 製備苯并咪唑衍生物之方法
JP2018529687A5 (enExample)
JP6580218B2 (ja) エナンチオマー濃縮された3−アミノピペリジンの調製のためのプロセス
JP2014533285A5 (enExample)
JP2013508368A5 (enExample)
CA2914381A1 (en) An efficient process for separation of diastereomers of 9-[(r)-2-[[(r,s)-[[(s)-1-(isopropoxycarbonyl)ethyl]amino]-phenoxyphosphinyl] methoxy]propyl]adenine
KR20150118146A (ko) 보르티옥세틴 제조 방법
HRP20191172T1 (hr) Proces za proizvodnju aminokiselina iz prekursora dobivenih anaerobnom fermentacijom iz fermentabilne biomase
JP2011520830A5 (enExample)
JP2011513297A5 (enExample)
JP2020502077A5 (enExample)
CN103467304A (zh) 一种盐酸西那卡塞的制备方法
JP2011506528A5 (enExample)
JP6228210B2 (ja) フルボキサミン遊離塩基の精製方法およびそれを用いた高純度フルボキサミンマレイン酸塩の製造方法
JP2015182974A (ja) トリエチレンテトラミンの製造方法
CN105085513A (zh) 一种制备(r)-3-奎宁环醇的方法
CN104030938A (zh) 盐酸丙帕他莫的制备方法
JP2016013989A5 (enExample)
CN104086460B (zh) 2-(甲基氨基)乙基氨基甲酸叔丁酯的合成方法
JP2012513391A5 (enExample)
CN108774140A (zh) 一种n-甲基邻苯二胺盐酸盐的合成方法
US10562879B2 (en) Method for preparing thienyl alanine having optical activity
JP6359940B2 (ja) ジフルオロメチルアセチレン化合物類及びその製造方法